In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer.
David J. Sher, MD, MPH
Advertisement
Articles by David J. Sher, MD, MPH
Ultimately, meaningful value assessment is going to require unbiased comparisons between competing strategies. Decision models are extremely useful in this regard and can provide important insight into cost-effectiveness evaluations.
Advertisement
Latest Updated Articles
- Defining the Value Research Agenda in Radiation Oncology
Published: April 15th 2017 | Updated:
David Sher on the Updated ASTRO Guidelines for Oropharyngeal CancerPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
3
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
4
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
5
